Carbapenem-resistant Pseudomonas aeruginosa infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China

被引:13
|
作者
Huang, Weichun [1 ]
Wei, Xiaoshu [2 ]
Xu, Guifeng [3 ]
Zhang, Xingyu [1 ]
Wang, Xing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Lab Med, Shanghai, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Nursing, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
carbapenem-resistant Pseudomonas aeruginosa; pediatric; risk factor; mortality; antimicrobial resistance; INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTIONS; EPIDEMIOLOGY; SURVEILLANCE; SEPSIS;
D O I
10.3389/fpubh.2023.1088262
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and aimsCarbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major cause of healthcare-associated infections worldwide, but comprehensive study of clinical characteristics for CRPA infections among critically ill children remains limited in China. The objective of this study was to determine the epidemiology, risk factors, and clinical outcomes of CRPA infections among critically ill pediatric patients in a large tertiary pediatric hospital in China. MethodsA retrospective case-control study of patients with P. aeruginosa infections was conducted in the three intensive care units (ICUs) of Shanghai Children's Medical Center from January 2016 to December 2021. All patients with CRPA infection in the ICUs were enrolled as case patients. Patients with carbapenem-susceptible P. aeruginosa (CSPA) infection were randomly selected as control patients in a ratio of 1:1. Clinical characteristics of those inpatients were reviewed through the hospital information system. Univariate and multivariate analyses were performed to evaluate risk factors associated with the development of CRPA infections and mortality of P. aeruginosa infections. ResultsA total of 528 cases of P. aeruginosa infection in the ICUs were enrolled in the 6-year study. The prevalence of CRPA and MDRPA (multidrug-resistance P. aeruginosa) was 18.4 and 25.6%, respectively. Significant risk factors related to CRPA infection were the length of hospitalization >28 days (OR = 3.241, 95% CI 1.622-6.473, p = 0.001), receiving invasive operations (OR = 2.393, 95% CI 1.196-4.788, p = 0.014) and a blood transfusion (OR = 7.003, 95% CI 2.416-20.297, p < 0.001) within 30 days before infection. Conversely, birth weight >= 2,500 g (OR = 0.278, 95% CI 0.122-0.635, p = 0.001) and breast nursing (OR = 0.362, 95% CI 0.168-0.777, p = 0.009) were significant protective factors against CRPA infections. The in-hospital mortality rate was 14.2%, and no difference in mortality was observed between patients with CRPA and CSPA infections. Platelet < 100 x 10(9)/L (OR = 5.729, 95% CI 1.048-31.308, p = 0.044) and serum urea <3.2 mmol/L (OR = 5.173, 95% CI 1.215-22.023, p = 0.026) were independent predictors for the mortality due to P. aeruginosa infection. ConclusionsOur findings provide insights into CRPA infections among critically ill children in China. They provide guidance in identifying patients that may be at high risk for a resistant infection and emphasize the importance of antimicrobial stewardship and infection control in hospitals.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Clinical and Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Infections in a Tertiary Hospital in China
    Cui, Zhiwen
    Wang, Lirui
    Feng, Min
    MICROBIAL DRUG RESISTANCE, 2023, 29 (09) : 401 - 406
  • [32] Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
    Yuan, Qing
    Guo, Lei
    Li, Bin
    Zhang, Sheng
    Feng, Haiting
    Zhang, Yan
    Yu, Meihong
    Hu, Hangbin
    Chen, Hongchao
    Yang, Qing
    Qu, Tingting
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [33] A retrospective analysis of carbapenem-resistant Acinetobacter baumannii infections in critically ill patients: Experience at a tertiary-care teaching hospital ICU
    Ferlicolak, Leyla
    Altintas, Neriman Defne
    Yoruk, Fugen
    JOURNAL OF INTENSIVE MEDICINE, 2024, 4 (02): : 181 - 186
  • [34] Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific
    Le Hello, Simon
    Falcot, Virginie
    Lacassin, Flore
    Mikulski, Marc
    Baumann, Francine
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (11-12) : 821 - 826
  • [35] Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients
    Pena, C.
    Guzman, A.
    Suarez, C.
    Dorninguez, M. A.
    Tubau, F.
    Pujoj, M.
    Gudiol, F.
    Ariza, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 1967 - 1971
  • [36] Risk factors associated with carbapenem-resistant Klebsiella pneumoniae bloodstream infections in a tertiary-care hospital in India
    Gupta, Priyanka
    Bollam, Neha
    Mehta, Yatin
    Sengupta, Sharmila
    Gandra, Sumanth
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (11): : 1418 - 1420
  • [37] Characteristics of Klebsiella bloodstream infections and risk factors for carbapenem-resistant Klebsiella infections in children
    Yahsi, Aysun
    Bayhan, Gulsum Iclal
    Arslan, Emel
    Gokdol, Muhammed Yasin
    Atay, Beyza Nur
    Karaciger, Seren
    Yuksek, Saliha Kanik
    Gulhan, Belgin
    Parlakay, Aslinur Ozkaya
    TRENDS IN PEDIATRICS, 2023, 4 (02): : 133 - 142
  • [38] Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A nationwide survey of tertiary hospitals in mainland China
    Zha, Lei
    Li, Shirong
    Ren, Zhichu
    Li, Xiang
    Zhang, Dayan
    Zou, Yi
    Pan, Lingling
    Xu, Qiancheng
    Rui, Zuqin
    Chen, Shanghua
    Yang, Gang
    Chen, Zhixiang
    Tefsen, Boris
    Guo, Jun
    JOURNAL OF INFECTION, 2022, 84 (06) : E108 - E110
  • [39] Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites
    Barron, Michelle A.
    Richardson, Kris
    Jeffres, Meghan
    McCollister, Bruce
    SPRINGERPLUS, 2016, 5
  • [40] Impact of Combination Antimicrobial Therapy on Mortality Risk for Critically Ill Patients with Carbapenem-Resistant Bacteremia
    Bass, Stephanie N.
    Bauer, Seth R.
    Neuner, Elizabeth A.
    Lam, Simon W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 3748 - 3753